IRIS
REFINI, ROSA METELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.487
EU - Europa 5.942
AS - Asia 2.777
SA - Sud America 414
AF - Africa 116
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 15.749
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.377
IT - Italia 1.389
RU - Federazione Russa 1.136
GB - Regno Unito 1.111
CN - Cina 871
SG - Singapore 823
IE - Irlanda 708
SE - Svezia 387
VN - Vietnam 382
BR - Brasile 334
DE - Germania 276
UA - Ucraina 270
FR - Francia 263
HK - Hong Kong 233
FI - Finlandia 155
IN - India 82
KR - Corea 71
TR - Turchia 71
ES - Italia 69
CA - Canada 55
ZA - Sudafrica 53
BD - Bangladesh 47
MX - Messico 38
PL - Polonia 34
IQ - Iraq 32
BE - Belgio 30
AR - Argentina 26
CZ - Repubblica Ceca 26
JP - Giappone 26
PK - Pakistan 20
ID - Indonesia 16
EC - Ecuador 15
MA - Marocco 15
NL - Olanda 15
NG - Nigeria 14
AT - Austria 13
CI - Costa d'Avorio 12
IR - Iran 12
LT - Lituania 12
PH - Filippine 11
SA - Arabia Saudita 11
CL - Cile 10
AZ - Azerbaigian 9
UZ - Uzbekistan 9
JO - Giordania 8
PT - Portogallo 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
IL - Israele 6
LB - Libano 6
UY - Uruguay 6
DK - Danimarca 5
DZ - Algeria 5
KZ - Kazakistan 5
PE - Perù 5
RO - Romania 5
CH - Svizzera 4
HU - Ungheria 4
JM - Giamaica 4
KE - Kenya 4
PY - Paraguay 4
SN - Senegal 4
AL - Albania 3
BG - Bulgaria 3
CO - Colombia 3
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
IS - Islanda 3
KG - Kirghizistan 3
NP - Nepal 3
TT - Trinidad e Tobago 3
BO - Bolivia 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TW - Taiwan 2
AQ - Antartide 1
BH - Bahrain 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
Totale 15.743
Salva come PNG Salva come JPEG
Città #
Southend 977
Dallas 714
Dublin 700
Fairfield 674
Singapore 506
Ashburn 498
Chandler 391
Santa Clara 332
Moscow 321
Woodbridge 302
Seattle 283
Beijing 276
Houston 258
Siena 234
Wilmington 231
Jacksonville 222
San Jose 220
Hong Kong 216
Cambridge 213
Ann Arbor 155
Princeton 117
Ho Chi Minh City 115
New York 114
Dearborn 96
Helsinki 90
Los Angeles 87
Hanoi 85
Hefei 84
The Dalles 73
Munich 70
Seoul 69
Lastra a Signa 68
Lauterbourg 66
Nanjing 60
Florence 59
Milan 58
Council Bluffs 56
Boardman 53
Johannesburg 49
Gavirate 48
San Mateo 45
Izmir 44
Málaga 43
Shanghai 38
Buffalo 37
São Paulo 37
San Diego 35
Dong Ket 32
Nanchang 32
Catania 31
Rome 30
Warsaw 29
Orem 28
Chennai 27
London 26
Turku 24
Frankfurt am Main 23
Fremont 23
Tokyo 23
Changsha 22
Da Nang 20
Haiphong 19
Montreal 19
Brussels 18
Chicago 18
Columbus 18
Düsseldorf 16
Guangzhou 16
Hebei 16
Redondo Beach 16
Atlanta 15
Manchester 15
Baghdad 14
Brooklyn 14
Poplar 14
Shenyang 14
Stockholm 14
Boston 13
Brno 13
Kunming 13
Lahore 13
Toronto 13
Abidjan 12
Abuja 12
Hangzhou 12
Menlo Park 12
Mexico City 12
Norwalk 12
San Francisco 12
Denver 11
Dhaka 11
Jakarta 11
Olomouc 11
Phoenix 11
Prato 11
Bengaluru 10
Jiaxing 10
Rio de Janeiro 10
Tianjin 10
Trieste 10
Totale 10.410
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 1.039
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls 351
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 349
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 342
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 305
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 278
Exhaled nitric oxide in interstitial lung diseases 271
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 271
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 268
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 261
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model 256
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 256
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses 252
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 252
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 250
Prognostic bioindicators in severe COVID-19 patients 244
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 243
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 243
Calgranulin B (S100A9/MRP14): a Key molecule in idiopathic pulmonary fibrosis? 242
Omalizumab treatment in Samter's triad: case series and review of the literature 242
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress 240
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma 235
A functional proteomics approach to the comprehension of sarcoidosis 232
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 232
Could NSAIDs have a role as antiasthmatic agents? 229
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 223
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 222
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 219
NK and NKT-like cells in granulomatous and fibrotic lung diseases 216
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 211
Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium 209
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 208
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 207
Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin 206
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 204
Serum analysis of coagulation factors in IPF and NSIP 203
Postoperative acute kidney injury in lung transplant recipients 202
Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions 199
Chitotriosidase: a sensitive biomarker of sarcoidosis 198
Proteomic investigation of pulmonary sarcoidosis 197
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 196
Inhaled loop diuretics as potential new anti-asthmatic drugs 193
IPF mortality in waiting list for lung transplantation 188
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 187
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 187
Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome 183
Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma 179
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 173
P172 Pulmonary Hypertension In Ipf: Utility Of Hrct 168
Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics 166
Immunologic responses to antifibrotic treatment in IPF patients 165
Familial pulmonary fibrosis: Clinical-functional and radiological features 163
New concepts in the pathogenesis of sarcoidosis 162
Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis. 160
Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review 159
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 157
Exhaled carbon monoxide in sarcoidosis 157
Utility of spiral CAT scan in the follow-up of patients with pulmonary Largerhans cell histiocytosis 149
Protective activity of inhaled nonsteroidal antiinflammatory drugs on bronchial responsiveness to ultrasonically nebulized water 149
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 145
null 143
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 142
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 140
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 137
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 134
Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate 129
The effectiveness of nintedanib in patients with idiopathic pulmonary fibrosis, familial pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world study 125
null 121
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 111
null 106
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 103
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 102
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 97
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 93
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 80
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 72
null 63
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 46
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 36
The value of urinary calcium as biomarker in chronic sarcoidosis 34
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy 32
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases 26
Totale 15.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 0 0 0 0 0 133 131 106
2021/20221.044 71 132 79 91 52 30 49 43 34 108 149 206
2022/20231.328 85 137 159 167 131 241 50 102 137 57 38 24
2023/20241.200 39 21 104 54 59 306 399 36 8 38 21 115
2024/20252.156 135 99 246 77 297 144 109 103 147 103 237 459
2025/20264.747 377 604 599 658 1.113 208 662 127 148 251 0 0
Totale 15.965